Tandem Diabetes Care TNDM Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's allowance for doubtful accounts receivable (current)?
- Tandem Diabetes Care (TNDM) reported allowance for doubtful accounts receivable (current) of $6.91M in Q1 2026.
- How has Tandem Diabetes Care's allowance for doubtful accounts receivable (current) changed year-over-year?
- Tandem Diabetes Care's allowance for doubtful accounts receivable (current) decreased by 3.0% year-over-year, from $7.13M to $6.91M.
- What is the long-term trend for Tandem Diabetes Care's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's allowance for doubtful accounts receivable (current) has grown at a 16.8% compound annual growth rate (CAGR), from $3.86M to $8.39M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.